Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Oct 11, 2016
Insider Transaction Report
Form 4
LEBKOWSKI JANE
Pres., Research & Development
Transactions
- Tax Payment
Common Stock
2016-10-06−2,537→ 13,121 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,752 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Excludes 6,752 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.